Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astellas, Beigene, Bharat Biotech International, Canbridge, Cansino Biologics, Dizal, Eisai, GC, Glaxosmithkline, Hightide, Merck, Moderna, Novavax, Ocugen, RDIF, Sanofi, Seagen, Swedish Orphan Biovitrum, Transthera Sciences, Valneva.